Therapies such as Thymosin Alpha-1, LL-37, and Glutathione are frequently used to strengthen immune resilience and reduce chronic inflammatory stress
Patients on efimosfermin therapy had a statistically significant higher rate of MASH resolution without worsening of fibrosis (68% vs 29%, p 1 stage of fibrosis improvement without worsening of MASH, and 63.4% achieved MASH resolution without worsening of fibrosis
prescription momentum though reimburses more conservatively, whereas Mexicos private sector drives growth as public funding remains fragmented
Sattar N, Verma S, Sourij H, Wilson J, Stefanski A, Zhang X, Griffin R (2024) Inflammatory biomarkers in people treated with tirzepatide living with overweight or obesity, without and with T2D: a post-hoc analysis from SURMOUNT-1 and SURMOUNT-2
Human Reproduction , 32(2), 315-324
Sales of Rybelsus reached about $1.63 billion last year, more than double the 2021 figure